Results 211 to 220 of about 85,640 (310)

Specific features of immune ageing are detected in the earliest stages in rheumatoid arthritis development. [PDF]

EBioMedicine
Raza K, Sharma-Oates A, Padyukov L, van der Helm-van Mil AHM, Pratt AG, Jones SW, Filer A, Lord JM, Duggal NA.   +8 more
europepmc   +1 more source

Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques [PDF]

, 2017
Diamond, Michael S, et al,, Fox, Julie M, Sukulpovi-Petty, Soila   +3 more
core   +1 more source

TNF Inhibitor‐Induced Sarcoidosis‐Like Lesions in Inflammatory Bowel Disease

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background While tumor necrosis factor (TNF) inhibitors can induce paradoxical reactions, sarcoidosis‐like disease has hardly been reported so far. This study aimed to describe the epidemiological, diagnostic and therapeutic features of TNF inhibitor‐induced sarcoidosis‐like lesions in patients with inflammatory bowel disease.
Zlata Chkolnaia, Benedicte Lebrun‐Vignes, Aurelien Amiot, Mathieu Uzzan, Nicolas Richard, Maeva Charkaoui, Guillaume Le Cosquer, Carmen Stefanescu, Melanie Serrero, Laurianne Plastaras, Sophie Vieujean, David Laharie, Philippe Seksik   +12 more
wiley   +1 more source

THU0068 The risk of individual autoantibodies, autoantibody combinations and autoantibody levels for arthritis development in clinically suspect arthralgia [PDF]

, 2017
RM Ten Brinck, HW van Steenbergen, MA van Delft, MK Verheul, RE Toes, Leendert A. Trouw, AH van der Helm-van Mil   +6 more
openalex   +1 more source

Low ICU Admission and Excellent Outcomes in MIS‐C: A Swedish Study From an Open Society

Acta Paediatrica, Volume 115, Issue 2, Page 335-344, February 2026.
ABSTRACT Aim During the COVID‐19 pandemic, Sweden chose a more open public health approach. A general concern was that this approach would affect the population negatively. We describe the Swedish national MIS‐C cohort and risk factors for severe disease defined as admission to the intensive care unit and cardiogenic shock.
Petra Król, Maria Altman, Stefan Berg, Lillemor Berntson, Petter Brodin, Anders Fasth, Robin Kahn, Jenny Lingman Framme, Maria Mossberg, Charlotta Nordenhäll, Karin Palmblad, André Rudolph, Eva Säve‐Söderbergh, AnnaCarin Horne   +13 more
wiley   +1 more source

Systemic and dermatological findings of immunoglobulin A vasculitis in a black child: A case report. [PDF]

World J Clin Cases
Nurani KM, Natalia G, Kadernani N, Kadernani K.   +3 more
europepmc   +1 more source

Effectiveness and safety of abobotulinumtoxinA in pediatric lower limb spasticity: A phase IV, prospective, observational, multicenter study

Developmental Medicine &Child Neurology, Volume 68, Issue 2, Page 227-239, February 2026.
Abstract Aim To assess the longitudinal attainment of patient‐centered, function‐related Goal Attainment Scaling Total (GAS T)‐score after repeated abobotulinumtoxinA (AboBoNT‐A) injections over a period of up to 30 months and up to 10 cycles. Method In this prospective observational study, the investigators' clinical practices recruited patients aged ...
Mark E. Gormley, Edward Dabrowski, Mauricio R. Delgado, Ann Tilton, Asare Christian, Sarah Helen Evans, Anne‐Sophie Grandoulier, Jumaah Goldberg   +7 more
wiley   +1 more source

Symptoms Associated With Gadolinium Exposure: Different Patterns and Rates Between Linear and Macrocyclic Gadolinium-Based Contrast Agents. [PDF]

Invest Radiol
Shahid I, Lancelot E.
europepmc   +1 more source

PIONEER REAL Saudi Arabia: A multicentre, prospective, real‐world study of once‐daily oral semaglutide use in adults with type 2 diabetes in Saudi Arabia

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1304-1314, February 2026.
Abstract Aim PIONEER REAL Saudi Arabia investigated real‐world clinical outcomes associated with the use of once‐daily oral semaglutide in adults with type 2 diabetes (T2D). Materials and Methods This was a 34‐ to 44‐week multicentre, prospective, open‐label study in adults with T2D, who were treatment‐naive to injectable glucose‐lowering medication ...
Hussein ElBadawi, Nader Albalkhi, Ibrahim Al Kadhim, Ahmed Elsadig, Dimitrios Baltzis, Mohamed Hassan Hatahet, Mahmoud Ismail, Said Khader, Christina Louise Rasmussen, Stine Hedegaard Scheuer, Ahmed Shalaby, Mohammed Almehthel   +11 more
wiley   +1 more source

Childhood Sjögren's Disease: A Literature Review of an Underrecognized Autoimmune Entity in Pediatric Rheumatology. [PDF]

Cureus
Márquez Romero U, Estrella López AS, Panchi Jima JC, Hidalgo Tapia EC, Callejas Torres EA, Suarez Piñeros JK.   +5 more
europepmc   +1 more source